Total buying$00 buys
YARW
Yarrow Bioscience, Inc.
Insider activity for last month from 09/30 to 10/30.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$00 sells
Net open-market+$0Buying minus selling
Active insiders5Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 30, 2026
Open-market transaction mix · 0 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 0 | 5 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (5)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- PL+$0
- AR+$0
- FR+$0
- RS+$0
- ZT+$0
YARW transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
YARWYarrow Bioscience, Inc. | Payton LoriCDO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
YARWYarrow Bioscience, Inc. | Alford RachaelCOO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
YARWYarrow Bioscience, Inc. | Frey RebeccaCEO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
YARWYarrow Bioscience, Inc. | Ryder StevenCMO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
YARWYarrow Bioscience, Inc. | Zeronda TylerCFO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period5transactionstxns
- A · Grants / awards · dominant5 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesCDO1
Chief executive officer1
Chief financial officer1
CMO1
COO1
Reported Holdings After
Separated by insider, security, and ownership type
Zeronda TylerStock Option (Right to Buy) · Direct
156,115Oct 29, 2026
Ryder StevenStock Option (Right to Buy) · Direct
113,137Oct 29, 2026
Frey RebeccaStock Option (Right to Buy) · Direct
465,857Oct 29, 2026
Alford RachaelStock Option (Right to Buy) · Direct
89,844Oct 29, 2026
Payton LoriStock Option (Right to Buy) · Direct
99,827Oct 29, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 30 → Oct 30
LessMore
Yarrow Bioscience, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Yarrow Bioscience, Inc.?
Payton Lori, Alford Rachael, Frey Rebecca, Ryder Steven, Zeronda Tyler.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.